Skip to main content
Financial charts and analysis for business valuation

Corporate Forensic Service

Contentious Business Valuation & Private Company Equity Appraisal

Formal corporate business valuations for contentious disputes, corporate splits, deadlocks, and litigation buyouts - selecting and defending valuation models under legal scrutiny.

Shareholder Dispute Expert is an international corporate finance advisory and forensic accounting expert witness practice specializing in independent business valuations and loss quantification for shareholder disputes, unfair prejudice petitions, partnership dissolutions, and contentious private equity actions. Instructions are accepted worldwide; UK reports are prepared to Civil Procedure Rules (CPR) Part 35 standards where applicable.

EBITDA Normalization in Contentious Valuations

Normalizing EBITDA strips excessive director remuneration, non-arm's-length intercompany pricing, personal expenses, non-recurring legal costs, and arbitrary management adjustments to reveal true maintainable earnings on an arm's-length basis.

Transfer pricing between sister entities and uncommercial leasing arrangements are common adjustment vectors in private shareholder litigation.

DCF, EBITDA Multiples, and Net Asset Methodologies

Contentious valuations typically triangulate discounted cash flow (DCF), capitalised earnings (EV/EBITDA or EBIT multiples), and adjusted net asset approaches. Expert witnesses must defend discount rates, peer selection, and normalization assumptions under Chancery Division scrutiny.

Valuation proportionality must align with dispute quantum and procedural stage in the High Court Chancery track.

Core Forensic Capabilities

  • Discounted Cash Flow projections using defensible WACC and growth assumptions
  • Capitalised earnings using normalized EBITDA multiples across peer markets
  • Adjusted Net Asset values for asset-backed corporate vehicles
  • Expert evidence on date of valuation - petition, exclusion, or hearing date

Typical Litigation Scenarios

  • Shareholder deadlock buyout negotiations
  • Corporate split and demerger valuations
  • Breach of shareholder agreement quantum assessments
  • Expert rebuttal of opposing valuation reports

Valuation Methodology Focus

  • Multi-track valuation triangulation (DCF, earnings, net assets)
  • Peer market comparable analysis and multiple selection
  • Control premium and minority discount defensibility
  • Sensitivity analysis for key assumption challenges

CPR Part 35 Mandate Assurance

Valuation reports structured for CPR Part 35 compliance with clear methodology statements, assumption disclosure, and range presentation where appropriate.

Require Independent Expert Evidence?

We prioritize conflict checking and respond to urgent instructions within 1 business day.

Instruct a Forensic Expert

Frequently Asked Questions

How is fair value determined in a UK shareholder dispute?
Fair value in private company shareholder disputes is generally determined by establishing the pro-rata enterprise value of the corporate entity as a whole, typically utilizing earnings multiples (EV/EBITDA) or discounted cash flow (DCF) models, and adjusting for normalization vectors. In cases of unfair prejudice under Section 994, the High Court frequently directs that the valuation should exclude any minority discount, treating the enterprise as a quasi-partnership to achieve an equitable exit.
What is a minority discount and when does it apply in Section 994 petitions?
A minority discount reflects the reduced commercial control and lack of marketability inherent in a minority shareholding block. In standard corporate transactions, this discount can range from 10% to over 50%. However, in Section 994 unfair prejudice petitions, if the corporate entity is classified as a 'quasi-partnership' founded on mutual trust and an assumption of active participation, the court typically rules that the petitioner's shares must be purchased at full pro-rata value without any minority discount application.
What date of valuation does the court apply in a shareholder buyout order?
The High Court retains absolute overriding discretion to determine the valuation date that achieves fairness. The default baseline is typically the date of the judicial determination (the trial date) or the date the petition was formally issued. If the majority has deliberately suppressed or siphoned company value post-exclusion, the court will backdate the valuation to the date of exclusion, or reconstruct the company's financial model to neutralize the prejudicial actions.
How does an expert witness normalize EBITDA for a contentious private company valuation?
Normalizing EBITDA involves adjusting a private company's historical profit-and-loss statements to reveal its true underlying maintainable earnings on an arm's-length commercial basis. A forensic accountant strips out excessive above-market director salaries, non-commercial intercompany transfer pricing, personal expenses run through the business, non-recurring transaction legal fees, and arbitrary management adjustments, aligning the financial baseline with real market conditions.
What absolute criteria must a business valuation report meet to be admissible under CPR Part 35?
To satisfy Civil Procedure Rules Part 35 and Practice Direction 35, a business valuation report must: be addressed explicitly to the court rather than the instructing client; document the expert's professional credentials; outline the explicit and implied instructions received; delineate the core facts, source accounts, and baseline assumptions applied; present clear technical reasoning for the chosen valuation metrics; define any applicable ranges of valuation opinions; provide a structured summary of financial conclusions; contain a formal statement confirming compliance with expert duties; and be signed under a strict regulatory statement of truth.